• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 2 fuera de 9 páginas
Examen

Annc Fnp Nursing Exam Practice Questions And Answers (Verified Answers)

Document preview thumbnail
Vista previa 2 fuera de 9 páginas

ANNC FNP NURSING EXAM PRACTICE QUESTIONS AND ANSWERS (VERIFIED ANSWERS)

Vista previa del contenido

ANCC Review Questions (PMHNP IQ)
Study online at https://quizlet.com/_6y26qb

1. What direct-acting dopamine receptor agonist is recommended to be used
in the treatments of neuroleptic malignant syndrome (NMS) fo help lower the
dopamine blockade?

A) benzotropine (Cogentin)
B) bromocriptine (Parlodel)
C) dantrolene (Dantrium)
D) trihexyphenidyl (Artane): A) Bromocriptine (Parlodel) is the recommended direct acting dopamine
receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a muscle relaxant. Benzotropine
(Cogentin) and Trihexyphenidyl (Artane) are anticholinergic medications used for extrapyramidal side effects (EPS).
2. Mr. Smith is a 56 year old white male who has been successfully treated on
Selegiline for over 4 years. Mr. Smith is going in for elective surgical procedure.
Which medication is strictly contraindicated with Selegiline?

A) Non-steroidal anti-inflammatory drugs (NSAIDS)
B) Codeine
C) Morphine
D) Meperidine: D) Meperidine is strictly prohibited when a patient is treated on a monoamine oxidase inhibitor
(MAOI) due to the risk of hypertensive crisis and death.
3. A WBC of 4,000 in a patient taking Clozapine would prompt the PMHNP to
take which of the following actions?

A) Consult with hematologist to determine appropriate antibiotic regimen and
monitor closely.
B) Institute twice-weekly complete blood count with differentials and monitor
closely.
C) Discontinue clozapine, initiate alternative antipsychotic medication and
monitor closely.
D) Institute daily complete blood count with differentials and monitor closely.-
: B) Institute twice-weekly complete blood count with differentials and monitor closely.

The recommended cut-points for discontinuation of clozapine are WBC of 2,000 to 3,000 or granulocytes of 1,000 to

1/9

, ANCC Review Questions (PMHNP IQ)
Study online at https://quizlet.com/_6y26qb

1,500 for agranulocytosis and severely compromised immune system. At a WBC of 4,000, the recommendation is to
closely monitor CBC with differential twice a week while patient may continue clozapine in the absence of any other
signs or symptoms.
4. A patient with a diagnosis of schizophrenia has a history of suicidal ideation
and suicide attempts. The PMHNP should consider which antipsychotic medica-
tion that is the only antipsychotic to reduce the risk of suicide in schizophrenia?

A) Abilify (aripriprazole)
B) Latuda (lurasidone)
C) Invega (iloperidone)
D) Clozaril (clozapine): D) Clozaril (clozapine) is the only known antipsychotic medication that had been
shown to reduce the risk of suicide in patients diagnosed with schizophrenia.
5. A patient being treated for major depressive disorder and on sertraline
(Zoloft), 150 mg po daily for the past 16 years, presents to the psychiatric
mental health practitioner for an outpatient follow-up visit. During the visit
she states that she has not been feeling well, reporting the flu. She also states
she has not taken her medication in the last five days. Which of the following
symptoms would she be describing if you suspect selective serotonin reputable
inhibitors (SSRIs) discontinuation syndrome?

A) Agitation, nausea, dysphoria, and diequilibrium
B) Agitation, nausea, tremor, and ataxia.
C) Restlessness, tremor, fever, and shivering.
D) Restlessness, headache, increased heart rate, and diarrhea.: A) Agitation; nausea,
dysphoria, and disequilibrium

The patient has SSRI discontinuation syndrome and would be presenting with flu-like symptoms. If the patient had
serotonin syndrome, she would present with symptoms of autonomic instability.
6. Which of the following statements reflect the current understanding of
dopamine (DA) pathways and clinical symptoms in schizophrenia?

A) Negative symptoms are related to DA deficit in the cerebral cortex; positive

2/9

Información del documento

Subido en
22 de marzo de 2026
Número de páginas
9
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$19.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
1
Seguidores
0
Artículos
655
Última venta
2 meses hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes